The DOI matches its Crossref record.
Reactivation of Pituitary Hormone Release and Metabolic Improvement by Infusion of Growth Hormone-Releasing Peptide and Thyrotropin-Releasing Hormone in Patients with Protracted Critical Illness1
Abstract
Protracted critical illness is marked by protein wasting resistant to feeding, by accumulation of fat stores, and by suppressed pulsatile release of GH and TSH. We previously showed that the latter can be reactivated by brief infusion of GH-releasing peptide (GHRP-2) and TRH. Here, we studied combined GHRP-2 and TRH infusion for 5 days, which allowed a limited evaluation of the metabolic effectiveness of this novel trophic endocrine strategy. Fourteen patients (mean ± sd age, 68 ± 11 yr), critically ill for 40 ± 28 days, were compared to a matched group of community-living control subjects at baseline and subsequently received 5 days of placebo and 5 days of GHRP-2 plus TRH (1+1μ g/kg·h) infusion in random order. At baseline, impaired anabolism, as indicated by biochemical markers (osteocalcin and leptin), was linked to hyposomatotropism [reduced pulsatile GH secretion, as determined by deconvolution analysis, and low GH-dependent insulin-like growth factor and binding protein (IGFBP) levels]. Biochemical markers of accelerated catabolism (increased protein degradation and bone resorption) were related to tertiary hypothyroidism and the serum concentration of IGFBP-1, but not to hyposomatotropism. Metabolic markers were independent of elevated serum cortisol. After 5 days of GHRP-2 plus TRH infusion, osteocalcin concentrations increased 19% vs. −6% with placebo, and leptin had rose 32% vs. -15% with placebo. These anabolic effects were linked to increased IGF-I and GH-dependent IGFBP, which reached near-normal levels from day 2 onward. In addition, protein degradation was reduced, as indicated by a drop in the urea/creatinine ratio, an effect that was related to the correction of tertiary hypothyroidism, with near-normal thyroid hormone levels reached and maintained from day 2 onward. Concomitantly, a spontaneous tendency of IGFBP-1 to rise and of insulin to decrease was reversed. Cortisol concentrations were not detectably altered. In conclusion, 5-day infusion of GHRP-2 plus TRH in protracted critical illness reactivates blunted GH and TSH secretion, with preserved pulsatility, peripheral responsiveness, and feedback inhibition and without affecting serum cortisol, and induces a shift toward anabolic metabolism. This provides the first evidence of the metabolic effectiveness of short term GHRP-2 plus TRH agonism in this particular wasting condition.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Intensive insulin therapy in critically ill patients.
Van den Berghe, G., Wouters, P., Weekers, F., Verwaest, C., Bruyninckx, F., Schetz, M., Vlasselaers, D., Ferdinande, P., Lauwers, P., & Bouillon, R. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011300 · Cited by 9,977
Self-citationGhrelin is a growth-hormone-releasing acylated peptide from stomach
Kojima, M., Hosoda, H., Date, Y., Nakazato, M., Matsuo, H., & Kangawa, K. (1999) · Nature · doi:10.1038/45230 · Cited by 8,479
Dixit, V. D., Schaffer, E. M., Pyle, R. S., Collins, G. D., Sakthivel, S. K., Palaniappan, R., Lillard, J. W., & Taub, D. D. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200421134 · Cited by 875
How does blood glucose control with insulin save lives in intensive care?
Van den Berghe, G. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200423506 · Cited by 550
Self-citationSelenium, the Thyroid, and the Endocrine System
Köhrle, J., Jakob, F., Contempré, B., & Dumont, J. E. (2005) · Endocrine Reviews · doi:10.1210/er.2001-0034 · Cited by 529
Thyroid function in critically ill patients
Fliers, E., Bianco, A. C., Langouche, L., & Boelen, A. (2015) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(15)00225-9 · Cited by 441
Jeng, L., Yamshchikov, A. V., Judd, S. E., Blumberg, H. M., Martin, G. S., Ziegler, T. R., & Tangpricha, V. (2009) · Journal of Translational Medicine · doi:10.1186/1479-5876-7-28 · Cited by 440
Mechanisms behind the non-thyroidal illness syndrome: an update
Warner, M. H., & Beckett, G. J. (2010) · Journal of Endocrinology · doi:10.1677/joe-09-0412 · Cited by 432
Association of low serum 25-hydroxyvitamin D levels and mortality in the critically ill*
Braun, A., Chang, D., Mahadevappa, K., Gibbons, F. K., Liu, Y., Giovannucci, E., & Christopher, K. B. (2011) · Critical Care Medicine · doi:10.1097/ccm.0b013e318206ccdf · Cited by 349
Fekete, C., & Lechan, R. M. (2014) · Endocrine Reviews · doi:10.1210/er.2013-1087 · Cited by 342
Non-Thyroidal Illness in the ICU: A Syndrome with Different Faces
Van den Berghe, G. (2014) · Thyroid® · doi:10.1089/thy.2014.0201 · Cited by 316
Defining the Roles of the Iodothyronine Deiodinases: Current Concepts and Challenges
St. Germain, D. L., Galton, V. A., & Hernandez, A. (2009) · Endocrinology · doi:10.1210/en.2008-1588 · Cited by 297
Beyond Low Plasma T3: Local Thyroid Hormone Metabolism during Inflammation and Infection
Boelen, A., Kwakkel, J., & Fliers, E. (2011) · Endocrine Reviews · doi:10.1210/er.2011-0007 · Cited by 287
Novel insights into the neuroendocrinology of critical illness
Van den Berghe, G. (2000) · European Journal of Endocrinology · doi:10.1530/eje.0.1430001 · Cited by 257
Bone Turnover in Prolonged Critical Illness: Effect of Vitamin D
Van den Berghe, G., Van Roosbroeck, D., Vanhove, P., Wouters, P. J., De Pourcq, L., & Bouillon, R. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030358 · Cited by 252
Self-citationBoelen, A., Kwakkel, J., Thijssen-Timmer, D., Alkemade, A., Fliers, E., & Wiersinga, W. (2004) · Journal of Endocrinology · doi:10.1677/joe.0.1820315 · Cited by 159
Endocrine aspects of acute and prolonged critical illness
Vanhorebeek, I., Langouche, L., & Van den Berghe, G. (2006) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0071 · Cited by 141
Van den Berghe, G., Baxter, R. C., Weekers, F., Wouters, P., Bowers, C. Y., Iranmanesh, A., Veldhuis, J. D., & Bouillon, R. (2002) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2002.01255.x · Cited by 134
Self-citationRejuvenation of the aging thymus: growth hormone-mediated and ghrelin-mediated signaling pathways
Taub, D. D., Murphy, W. J., & Longo, D. L. (2010) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2010.04.015 · Cited by 119
Thyrotropin secretion patterns in health and disease
Roelfsema, F., & Veldhuis, J. D. (2013) · Endocrine Reviews · doi:10.1210/er.2012-1076 · Cited by 113
Self-citationEndocrine Responses to Critical Illness: Novel Insights and Therapeutic Implications
Boonen, E., & Van den Berghe, G. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-4115 · Cited by 105
Thyroid axis function and dysfunction in critical illness
Mebis, L., & Van den Berghe, G. (2011) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2011.03.002 · Cited by 99
Stockigt, J. R., & Lim, C.-F. (2009) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2009.06.004 · Cited by 79
Langouche, L., Vander Perre, S., Marques, M., Boelen, A., Wouters, P. J., Casaer, M. P., & Van den Berghe, G. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2809 · Cited by 79
Self-citationThe hypothalamic-pituitary-thyroid axis in critical illness
Fliers, E., Alkemade, A., & Wiersinga, W. M. (2001) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1053/beem.2001.0163 · Cited by 69
Bowers, C. Y., Granda, R., Mohan, S., Kuipers, J., Baylink, D., & Veldhuis, J. D. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031799 · Cited by 57
Self-citationHormonal and metabolic strategies to attenuate catabolism in critically ill patients
Vanhorebeek, I., & Berghe, G. V. D. (2004) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2004.07.007 · Cited by 52
Self-citationAnterior pituitary function in critical illness
Téblick, A., Langouche, L., & Van den Berghe, G. (2019) · Endocrine Connections · doi:10.1530/ec-19-0318 · Cited by 52
Self-citationDifferential effects of fasting vs food restriction on liver thyroid hormone metabolism in male rats
de Vries, E. M., van Beeren, H. C., Ackermans, M. T., Kalsbeek, A., Fliers, E., & Boelen, A. (2015) · Journal of Endocrinology · doi:10.1530/joe-14-0533 · Cited by 38
Peeters, R. P., & Boelen, A. (2022) · Oxford Textbook of Endocrinology and Diabetes 3e · doi:10.1093/med/9780198870197.003.0042 · Cited by 3
Metadata
- Authors
- Van den Berghe, G., Wouters, P., Weekers, F., Mohan, S., Baxter, R. C., Veldhuis, J. D., Bowers, C. Y., & Bouillon, R.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 1999-04-01
- Volume
- 84
- Issue
- 4
- Pages
- 1311-1323
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2151292858
- Cited by
- 233
- References
- 0
- FWCI
- 8.94
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.